GEDEON RICHTER STARTS PRODUCING IN RUSSIA AN INNOVATIVE DRUG FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER
Gedeon Richter Ltd. launches production of Reagila (cariprazine) for patients suffering schizophrenia and bipolar disorder in Russia. Starting from July 26, 2021, the drug will be produced at the GEDEON…